UHS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Universal Health Services Inc. (UHS) is currently not a strong buy for a beginner, long-term investor. Despite solid financial growth in Q4 2025, the stock's technical indicators suggest bearish momentum, and insider selling raises concerns. Additionally, mixed analyst ratings and a lack of strong proprietary trading signals further support a cautious approach. Hold off on investing for now.
The stock is currently in a bearish trend with a negatively expanding MACD histogram (-0.937) and an oversold RSI (19.082). However, moving averages are bullish (SMA_5 > SMA_20 > SMA_200), indicating potential long-term support. Key support levels are at $209.81 and $200.13, with resistance at $225.48 and $241.15.
Q4 2025 revenue increased by 9.1% YoY to $4.49 billion.
Net income grew by 34.16% YoY, and EPS increased by 42.34% YoY.
Positive outlook for 2026 revenue growth of 6%-8%.
Insider selling increased by 291.34% over the last month.
Q4 2025 EPS of $5.88 missed analyst expectations, leading to a 9.4% drop in share price.
Mixed analyst ratings with some firms citing policy risks and weak core results.
No recent Congress trading data or strong proprietary trading signals.
In Q4 2025, revenue increased by 9.05% YoY to $4.49 billion, net income rose by 34.16% YoY to $445.94 million, and EPS grew by 42.34% YoY to $7.06. The company also maintained a stable gross margin.
Analyst ratings are mixed. Barclays raised its price target to $268, citing a positive EBITDA outlook, while BofA maintained an Underperform rating due to policy risks and weak core results. Other firms like Wells Fargo downgraded the stock, citing legislative risks and post-COVID headwinds.
